Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry.

Alonzi T, Petruccioli E, Vanini V, Fimia GM, Goletti D.

Eur J Histochem. 2019 Jun 26;63(2). doi: 10.4081/ejh.2019.3044.

2.

Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Massafra U, Baldi G, Navarra A, Scrivo R, Mastroianni C, Sauzullo I, Esposito C, Palmieri F, Cantini F, Goletti D.

J Infect. 2019 Jul;79(1):15-23. doi: 10.1016/j.jinf.2019.04.010. Epub 2019 Apr 11.

PMID:
30981891
3.

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection.

Petruccioli E, Chiacchio T, Vanini V, Cuzzi G, Codecasa LR, Ferrarese M, Schininà V, Palmieri F, Ippolito G, Goletti D.

Sci Rep. 2018 Oct 23;8(1):15626. doi: 10.1038/s41598-018-33825-w.

4.

First description of agonist and antagonist IP-10 in urine of patients with active TB.

Petrone L, Bondet V, Vanini V, Cuzzi G, Palmieri F, Palucci I, Delogu G, Ciccosanti F, Fimia GM, Blauenfeldt T, Ruhwald M, Duffy D, Goletti D.

Int J Infect Dis. 2019 Jan;78:15-21. doi: 10.1016/j.ijid.2018.09.001. Epub 2018 Sep 7.

5.

Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.

Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D.

Tuberculosis (Edinb). 2018 Jul;111:147-153. doi: 10.1016/j.tube.2018.06.005. Epub 2018 Jun 12.

6.

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions.

Blauenfeldt T, Petrone L, Del Nonno F, Baiocchini A, Falasca L, Chiacchio T, Bondet V, Vanini V, Palmieri F, Galluccio G, Casrouge A, Eugen-Olsen J, Albert ML, Goletti D, Duffy D, Ruhwald M.

Front Immunol. 2018 Jul 5;9:1456. doi: 10.3389/fimmu.2018.01456. eCollection 2018.

7.

Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV/M. tuberculosis-specific T-cell in co-infected subjects.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, La Manna MP, Orlando V, Pinnetti C, Sampaolesi A, Antinori A, Caccamo N, Goletti D.

Immunol Lett. 2018 Jun;198:33-43. doi: 10.1016/j.imlet.2018.04.001. Epub 2018 Apr 7.

8.

A T-cell diagnostic test for cystic echinococcosis based on Antigen B peptides.

Petrone L, Vanini V, Amicosante M, Corpolongo A, Gomez Morales MA, Ludovisi A, Ippolito G, Pozio E, Teggi A, Goletti D.

Parasite Immunol. 2017 Dec;39(12). doi: 10.1111/pim.12499.

9.

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.

Chiacchio T, Delogu G, Vanini V, Cuzzi G, De Maio F, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

PLoS One. 2017 Aug 24;12(8):e0183846. doi: 10.1371/journal.pone.0183846. eCollection 2017.

10.

Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.

Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D.

Tuberculosis (Edinb). 2017 Sep;106:38-43. doi: 10.1016/j.tube.2017.06.002. Epub 2017 Jun 27.

11.

Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.

Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Palmieri F, Cirillo DM, Ippolito G, Goletti D.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S25-S26. doi: 10.1016/j.ijmyco.2016.09.063. Epub 2016 Nov 11.

12.

Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection.

Petruccioli E, Vanini V, Chiacchio T, Cirillo DM, Palmieri F, Ippolito G, Goletti D.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S143-S144. doi: 10.1016/j.ijmyco.2016.09.029. Epub 2016 Nov 11.

13.

Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.

Chiacchio T, Petruccioli E, Pepponi I, Vanini V, Gualano G, Cirillo D, Palmieri F, Ippolito G, Goletti D.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S141-S142. doi: 10.1016/j.ijmyco.2016.09.034. Epub 2016 Nov 11.

14.

Blood and urine inducible protein 10 as potential markers of disease activity.

Petrone L, Cannas A, Vanini V, Cuzzi G, Aloi F, Nsubuga M, Sserunkuma J, Nazziwa RA, Jugheli L, Lukindo T, Girardi E, Antinori A, Pucci L, Reither K, Goletti D.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1554-1561.

PMID:
27776600
15.

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.

Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Cirillo DM, Palmieri F, Ippolito G, Goletti D.

J Infect. 2016 Dec;73(6):588-597. doi: 10.1016/j.jinf.2016.09.008. Epub 2016 Oct 4.

16.

Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.

Delogu G, Vanini V, Cuzzi G, Chiacchio T, De Maio F, Battah B, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

Scand J Immunol. 2016 Dec;84(6):344-352. doi: 10.1111/sji.12493.

17.

Use of several immunological markers to model the probability of active tuberculosis.

Petruccioli E, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Palmieri F, Girardi E, Goletti D.

Diagn Microbiol Infect Dis. 2016 Oct;86(2):169-71. doi: 10.1016/j.diagmicrobio.2016.06.007. Epub 2016 Jun 14.

PMID:
27431433
18.

Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment.

Joosten SA, van Meijgaarden KE, Del Nonno F, Baiocchini A, Petrone L, Vanini V, Smits HH, Palmieri F, Goletti D, Ottenhoff TH.

PLoS Pathog. 2016 Jun 15;12(6):e1005687. doi: 10.1371/journal.ppat.1005687. eCollection 2016 Jun.

19.

KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.

Boer MC, van Meijgaarden KE, Goletti D, Vanini V, Prins C, Ottenhoff TH, Joosten SA.

Tuberculosis (Edinb). 2016 Mar;97:163-71. doi: 10.1016/j.tube.2015.11.008. Epub 2015 Dec 8.

PMID:
26750180
20.

Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the Cysts.

Petrone L, Vanini V, Petruccioli E, Ettorre GM, Schininà V, Busi Rizzi E, Ludovisi A, Corpolongo A, Ippolito G, Pozio E, Teggi A, Goletti D.

PLoS Negl Trop Dis. 2015 Nov 17;9(11):e0004209. doi: 10.1371/journal.pntd.0004209. eCollection 2015 Nov.

21.

Early and mid-term outcome in terms of functional and hemodynamic performance of the st. Jude regent 19-mm aortic mechanical prosthesis versus 19-mm carpentier edwards aortic biological prosthesis.

Prifti E, Bonacchi M, Ademaj F, Giunti G, Esposito G, Baboci A, Bajraktari G, Veshti A, Demiraj A, Vanini V.

J Cardiothorac Surg. 2015 Nov 6;10:154. doi: 10.1186/s13019-015-0361-3.

22.

Does the St. Jude Regent 17-mm Offer Better Outcomes Than the Hemodynamic Plus 17-mm Aortic Valve Mechanical Prothesis?

Prifti E, Bonacchi M, Baboci A, Giunti G, Esposito G, Kajo E, Nuellari E, Vanini V.

J Card Surg. 2015 Nov;30(11):787-95. doi: 10.1111/jocs.12637. Epub 2015 Oct 7.

PMID:
26447362
23.

A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Carpenter C, Sidney J, Kolla R, Nayak K, Tomiyama H, Tomiyama C, Padilla OA, Rozot V, Ahamed SF, Ponte C, Rolla V, Antas PR, Chandele A, Kenneth J, Laxmi S, Makgotlho E, Vanini V, Ippolito G, Kazanova AS, Panteleev AV, Hanekom W, Mayanja-Kizza H, Lewinsohn D, Saito M, McElrath MJ, Boom WH, Goletti D, Gilman R, Lyadova IV, Scriba TJ, Kallas EG, Murali-Krishna K, Sette A, Lindestam Arlehamn CS.

Tuberculosis (Edinb). 2015 Dec;95(6):713-721. doi: 10.1016/j.tube.2015.07.001. Epub 2015 Aug 1.

24.

Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.

Petruccioli E, Petrone L, Vanini V, Cuzzi G, Navarra A, Gualano G, Palmieri F, Girardi E, Goletti D.

J Infect. 2015 Nov;71(5):526-33. doi: 10.1016/j.jinf.2015.07.009. Epub 2015 Aug 5.

PMID:
26253021
25.

Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease.

Guggino G, Orlando V, Cutrera S, La Manna MP, Di Liberto D, Vanini V, Petruccioli E, Dieli F, Goletti D, Caccamo N.

Immunol Lett. 2015 Aug;166(2):87-91. doi: 10.1016/j.imlet.2015.05.019. Epub 2015 Jun 5.

PMID:
26051682
26.

Hemodynamics of 17-mm vs. 19-mm St. Jude Medical Regent and annulus enlargement.

Prifti E, Bonacchi M, Baboci A, Giunti G, Esposito G, Krakulli K, Ademaj F, Kajo E, Vanini V.

Asian Cardiovasc Thorac Ann. 2015 Jul;23(6):670-83. doi: 10.1177/0218492315581574. Epub 2015 Apr 29.

PMID:
25931567
27.

Coil embolization of an anomalous bronchial artery originating from the left subclavian artery following arterial switch operation: a case report.

Prifti E, Ademaj F, Baboci A, Kajo E, Vanini V.

J Med Case Rep. 2015 Mar 8;9:55. doi: 10.1186/s13256-015-0540-9.

28.

Granulocytic myeloid derived suppressor cells expansion during active pulmonary tuberculosis is associated with high nitric oxide plasma level.

El Daker S, Sacchi A, Tempestilli M, Carducci C, Goletti D, Vanini V, Colizzi V, Lauria FN, Martini F, Martino A.

PLoS One. 2015 Apr 16;10(4):e0123772. doi: 10.1371/journal.pone.0123772. eCollection 2015.

29.

Endovascular treatment of superior vena cava obstruction after surgical correction of intracardiac total anomalous pulmonary venous connection.

Veshti A, Prifti E, Ballerini L, Vanini V.

World J Pediatr Congenit Heart Surg. 2015 Apr;6(2):288-90. doi: 10.1177/2150135114563940.

PMID:
25870349
30.

IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activity.

Petrone L, Vanini V, Petruccioli E, Ettorre GM, Busi Rizzi E, Schininà V, Girardi E, Ludovisi A, Gómez-Morales MÁ, Pozio E, Teggi A, Goletti D.

J Infect. 2015 Mar;70(3):299-306. doi: 10.1016/j.jinf.2014.10.009. Epub 2014 Oct 22.

PMID:
25444973
31.

Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, Antinori A, Girardi E, Goletti D.

J Infect. 2014 Dec;69(6):533-45. doi: 10.1016/j.jinf.2014.06.009. Epub 2014 Jun 26.

PMID:
24975174
32.

The peacock tail technique: a modified reconstruction technique for tricuspid valve repair in Ebstein's malformation.

Prifti E, Baboci A, Kajo E, Vanini V.

Ann Thorac Surg. 2014 Jun;97(6):e183-5. doi: 10.1016/j.athoracsur.2014.02.056.

PMID:
24882340
33.

One and a half ventricle repair in association with tricuspid valve repair according to "peacock tail" technique in patients with Ebstein's malformation and failing right ventricle.

Prifti E, Baboci A, Esposito G, Kajo E, Dado E, Vanini V.

J Card Surg. 2014 May;29(3):383-9. doi: 10.1111/jocs.12321.

PMID:
24762038
34.

High urine IP-10 levels associate with chronic HCV infection.

Petrone L, Chiacchio T, Vanini V, Petruccioli E, Cuzzi G, Di Giacomo C, Pucci L, Montalbano M, Lionetti R, Testa A, Lapa D, Navarra A, Visco-Comandini U, Goletti D.

J Infect. 2014 Jun;68(6):591-600. doi: 10.1016/j.jinf.2014.02.008. Epub 2014 Feb 26.

PMID:
24582930
35.

Surgical outcome of reoperation due to left atrioventricular valve regurgitation after previous correction of complete atrioventricular septal defect.

Prifti E, Bonacchi M, Baboci A, Giunti G, Krakulli K, Vanini V.

J Card Surg. 2013 Nov;28(6):756-63. doi: 10.1111/jocs.12231.

PMID:
24224745
36.

IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis.

Petruccioli E, Petrone L, Vanini V, Sampaolesi A, Gualano G, Girardi E, Palmieri F, Goletti D.

J Infect. 2013 Jun;66(6):475-86. doi: 10.1016/j.jinf.2013.02.004. Epub 2013 Feb 24.

PMID:
23462597
37.

IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.

Vanini V, Petruccioli E, Gioia C, Cuzzi G, Orchi N, Rianda A, Alba L, Giancola ML, Conte A, Schininà V, Rizzi EB, Girardi E, Goletti D.

J Infect. 2012 Jul;65(1):49-59. doi: 10.1016/j.jinf.2012.03.017. Epub 2012 Mar 29.

PMID:
22465752
38.

Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.

Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, Matteucci G, Lauria FN, Franken KL, Girardi E, Ottenhoff TH, Goletti D.

PLoS One. 2011;6(11):e27539. doi: 10.1371/journal.pone.0027539. Epub 2011 Nov 10.

39.

Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.

Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, Molicotti P, Zanetti S, Lauria FN, Grisetti S, Magnavita N, Fadda G, Girardi E, Goletti D.

PLoS One. 2011 Mar 29;6(3):e18315. doi: 10.1371/journal.pone.0018315.

40.

IP-10 detection in urine is associated with lung diseases.

Cannas A, Calvo L, Chiacchio T, Cuzzi G, Vanini V, Lauria FN, Pucci L, Girardi E, Goletti D.

BMC Infect Dis. 2010 Nov 22;10:333. doi: 10.1186/1471-2334-10-333.

41.

New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.

Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, Meraviglia S, Guggino G, Dieli F, Vecchi M, Lauria FN, Marruchella A, Laurenti P, Singh M, Caccamo N, Girardi E, Goletti D.

BMC Infect Dis. 2009 Nov 21;9:182. doi: 10.1186/1471-2334-9-182.

42.

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection.

Goletti D, Butera O, Vanini V, Lauria FN, Lange C, Franken KL, Angeletti C, Ottenhoff TH, Girardi E.

Eur Respir J. 2010 Jul;36(1):135-42. doi: 10.1183/09031936.00140009. Epub 2009 Nov 19.

43.

Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls.

Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, Vanini V, Girardi E, Goletti D, D' Amelio R, Nisini R.

Clin Microbiol Infect. 2010 Aug;16(8):1282-4. doi: 10.1111/j.1469-0691.2009.03104.x. Epub 2009 Nov 2.

44.

Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.

Chiacchio T, Casetti R, Butera O, Vanini V, Carrara S, Girardi E, Di Mitri D, Battistini L, Martini F, Borsellino G, Goletti D.

Clin Exp Immunol. 2009 Jun;156(3):463-70. doi: 10.1111/j.1365-2249.2009.03908.x.

45.

A study of the Fontan circulation and ventricular energetics based on a model.

Ripoli A, Berti S, Glauber M, Vanini V, Luisi VS, Biagini A.

Cardiol Young. 2004;14 Suppl 3:11-9. No abstract available.

PMID:
15903096
46.

Double-flap technique for repair of anomalous origin of right pulmonary artery from ascending aorta.

Prifti E, Bonacchi M, Vanini V, Bartolozzi F.

Ann Thorac Surg. 2004 Nov;78(5):1883-4. No abstract available.

PMID:
15511514
47.
48.

Repair of complete atrioventricular septal defects in patients weighing less than 5 kg.

Prifti E, Bonacchi M, Bernabei M, Crucean A, Murzi B, Bartolozzi F, Luisi VS, Leacche M, Vanini V.

Ann Thorac Surg. 2004 May;77(5):1717-26.

PMID:
15111173
49.

Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines.

Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S.

Blood. 2004 Apr 15;103(8):3117-21. Epub 2003 Dec 24.

PMID:
15070693
50.

Repair of complete atrioventricular septal defect with tetralogy of fallot: our experience and literature review.

Prifti E, Bonacchi M, Bernabei M, Leacche M, Bartolozzi F, Murzi B, Battaglia F, Nadia NS, Vanini V.

J Card Surg. 2004 Mar-Apr;19(2):175-83. Review.

PMID:
15016061

Supplemental Content

Loading ...
Support Center